Richard Stone, MD, Physician, Hematologic Oncology, Internal Medicine, @DanaFarber offers his impression of the landscape for FLT3 inhibition in acute myeloid leukemia (AML).
Landscape for FLT3 Inhibition in AML @DanaFarber
Advertisement